$5.17
0.244.87%
At close: -
$5.58
0.417.93%
After Hours: Apr 11, 4:07 PM EDT
Comments
Loading...
Coya Therapeutics (COYA) Forecast
NewsEarningsCoya Therapeutics (COYA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Coya Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:COYA | Benzinga
Explore Coya Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for COYA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Coya Therapeutics (COYA) stock?
You can purchase shares of Coya Therapeutics (NASDAQ:COYA) through any online brokerage.
Who are Coya Therapeutics (COYA) competitors?
Other companies in Coya Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT) and OncoCyte (NASDAQ:OCX).
What is the forecast, or price target, for Coya Therapeutics (COYA) stock?
Coya Therapeutics has a consensus price target of $18.50.
What is the current price for Coya Therapeutics (COYA)?
The stock price for Coya Therapeutics (NASDAQ: COYA) is $5.58 last updated April 11, 2025 at 4:07 PM EDT.
Does Coya Therapeutics (COYA) pay a dividend?
There are no upcoming dividends for Coya Therapeutics.
When is Coya Therapeutics (NASDAQ:COYA) reporting earnings?
Coya Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Coya Therapeutics (COYA) going to split?
There is no upcoming split for Coya Therapeutics.
What sector and industry does Coya Therapeutics (COYA) operate in?
Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.